236 related articles for article (PubMed ID: 33946414)
21. Polymer-free electrospun nanofibers from sulfobutyl ether
Yildiz ZI; Celebioglu A; Uyar T
Int J Pharm; 2017 Oct; 531(2):550-558. PubMed ID: 28445768
[TBL] [Abstract][Full Text] [Related]
22. Preparation, characterisation and antitumour activity of β-, γ- and HP-β-cyclodextrin inclusion complexes of oxaliplatin.
Zhang D; Zhang J; Jiang K; Li K; Cong Y; Pu S; Jin Y; Lin J
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():501-8. PubMed ID: 26254603
[TBL] [Abstract][Full Text] [Related]
23. Development and characterization of inhalable transferrin functionalized amodiaquine nanoparticles - Efficacy in Non-Small Cell Lung Cancer (NSCLC) treatment.
Parvathaneni V; Shukla SK; Kulkarni NS; Gupta V
Int J Pharm; 2021 Oct; 608():121038. PubMed ID: 34438008
[TBL] [Abstract][Full Text] [Related]
24. Halting ionic shuttle to disrupt the synthetic machinery-Structural and molecular insights into the inhibitory roles of Bedaquiline towards Mycobacterium tuberculosis ATP synthase in the treatment of tuberculosis.
Salifu EY; Agoni C; Olotu FA; Dokurugu YM; Soliman MES
J Cell Biochem; 2019 Sep; 120(9):16108-16119. PubMed ID: 31125144
[TBL] [Abstract][Full Text] [Related]
25. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
26. Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer.
Shukla SK; Kulkarni NS; Farrales P; Kanabar DD; Parvathaneni V; Kunda NK; Muth A; Gupta V
Pharm Res; 2020 Mar; 37(3):67. PubMed ID: 32166411
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Thymoquinone-Sulfobutylether-β-Cyclodextrin Inclusion Complex for Anticancer Applications.
Eid EEM; Almaiman AA; Alshehade SA; Alsalemi W; Kamran S; Suliman FO; Alshawsh MA
Molecules; 2023 May; 28(10):. PubMed ID: 37241838
[TBL] [Abstract][Full Text] [Related]
28. Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics.
Vaidya B; Kulkarni NS; Shukla SK; Parvathaneni V; Chauhan G; Damon JK; Sarode A; Garcia JV; Kunda N; Mitragotri S; Gupta V
Int J Pharm; 2020 Mar; 577():118995. PubMed ID: 31935471
[TBL] [Abstract][Full Text] [Related]
29. Inclusion complex of GA-13316 with β-cyclodextrin: preparation, characterization, molecular modeling, and in vitro evaluation.
Yang R; Chen JB; Xiao CF; Liu ZC; Gao ZY; Yan SJ; Zhang JH; Zhang HB; Lin J
Carbohydr Polym; 2014 Oct; 111():655-62. PubMed ID: 25037400
[TBL] [Abstract][Full Text] [Related]
30. Ionophoric effects of the antitubercular drug bedaquiline.
Hards K; McMillan DGG; Schurig-Briccio LA; Gennis RB; Lill H; Bald D; Cook GM
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7326-7331. PubMed ID: 29941569
[TBL] [Abstract][Full Text] [Related]
31. Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives.
Salifu EY; Agoni C; Olotu FA; Soliman MES
Comput Biol Chem; 2020 Apr; 85():107204. PubMed ID: 31981966
[TBL] [Abstract][Full Text] [Related]
32. Cyclodextrin encapsulation enabling the anticancer repositioning of disulfiram: Preparation, analytical and in vitro biological characterization of the inclusion complexes.
Benkő BM; Tóth G; Moldvai D; Kádár S; Szabó E; Szabó ZI; Kraszni M; Szente L; Fiser B; Sebestyén A; Zelkó R; Sebe I
Int J Pharm; 2024 May; 657():124187. PubMed ID: 38697585
[TBL] [Abstract][Full Text] [Related]
33. Supramolecular strategy for reducing the cardiotoxicity of bedaquiline without compromising its antimycobacterial efficacy.
Kuok KI; In Ng PC; Ji X; Wang C; Yew WW; Chan DPC; Zheng J; Lee SMY; Wang R
Food Chem Toxicol; 2018 Sep; 119():425-429. PubMed ID: 29258954
[TBL] [Abstract][Full Text] [Related]
34. Characterization and molecular modeling of the inclusion complexes of 2-(2-nitrovinyl) furan (G-0) with cyclodextrines.
Ruz V; Froeyen M; Busson R; González MM; Baudemprez L; Van den Mooter G
Int J Pharm; 2012 Dec; 439(1-2):275-85. PubMed ID: 22989977
[TBL] [Abstract][Full Text] [Related]
35. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
Zheng Y; Haworth IS; Zuo Z; Chow MS; Chow AH
J Pharm Sci; 2005 May; 94(5):1079-89. PubMed ID: 15793810
[TBL] [Abstract][Full Text] [Related]
36. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
[TBL] [Abstract][Full Text] [Related]
37. Application of sodium sulfobutylether-β-cyclodextrin based on encapsulation.
Huang J; Wang X; Huang T; Yang Y; Tu J; Zou J; Yang H; Yang R
Carbohydr Polym; 2024 Jun; 333():121985. PubMed ID: 38494236
[TBL] [Abstract][Full Text] [Related]
38. Thymol/cyclodextrin inclusion complex nanofibrous webs: Enhanced water solubility, high thermal stability and antioxidant property of thymol.
Celebioglu A; Yildiz ZI; Uyar T
Food Res Int; 2018 Apr; 106():280-290. PubMed ID: 29579928
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the host-guest complex of a curcumin analog with β-cyclodextrin and β-cyclodextrin-gemini surfactant and evaluation of its anticancer activity.
Poorghorban M; Das U; Alaidi O; Chitanda JM; Michel D; Dimmock J; Verrall R; Grochulski P; Badea I
Int J Nanomedicine; 2015; 10():503-15. PubMed ID: 25609956
[TBL] [Abstract][Full Text] [Related]
40. A new complex of curcumin with sulfobutylether-β-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells.
Cutrignelli A; Lopedota A; Denora N; Iacobazzi RM; Fanizza E; Laquintana V; Perrone M; Maggi V; Franco M
J Pharm Sci; 2014 Dec; 103(12):3932-3940. PubMed ID: 25302947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
